Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
January 31, 2001
Primary Completion Date
January 31, 2006
Conditions
Liver Cancer
Interventions
DIETARY_SUPPLEMENT
Sho-saiko-to
Trial Locations (1)
10021
Memorial Sloan-Kettering Cancer Center, New York
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Memorial Sloan Kettering Cancer Center
OTHER
NCT00040898 - Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed | Biotech Hunter | Biotech Hunter